Publikationen in Zusammenarbeit mit Forschern von Hospital General Universitario de Valencia (204)

2024

  1. KRAS-mutant non-small cell lung cancer (NSCLC) therapy based on tepotinib and omeprazole combination

    Cell Communication and Signaling, Vol. 22, Núm. 1

  2. SEAP-IAP recommendations for the collection, storage and use of biological materials of human origin and related data intended for research. Generic biobank consideration and ethical-legal review (Part II)

    Revista Espanola de Patologia, Vol. 57, Núm. 4, pp. 250-257

  3. Soluble galectin-3 as a microenvironment-relevant immunoregulator with prognostic and predictive value in lung adenocarcinoma

    Molecular Oncology, Vol. 18, Núm. 1, pp. 190-215

  4. Times and conditions of storage of samples in anatomic pathology. Recommendations of the Spanish Society of Anatomic Pathology (SEAP) part 1: samples for diagnosis

    Revista Espanola de Patologia, Vol. 57, Núm. 4, pp. 235-249

2023

  1. A Sonic Hedgehog Pathway Score to Predict the Outcome of Resected Non-Small Cell Lung Cancer Patients

    Annals of Surgical Oncology, Vol. 30, Núm. 2, pp. 1225-1235

  2. ASO Visual Abstract: A Sonic Hedgehog Pathway Score to Predict the Outcome of Resected Non-small Cell Lung Cancer Patients

    Annals of surgical oncology, Vol. 30, Núm. 2, pp. 1238-1239

  3. Circulating Immune Proteins: Improving the Diagnosis and Clinical Outcome in Advanced Non-Small Cell Lung Cancer

    International Journal of Molecular Sciences, Vol. 24, Núm. 24

  4. Clinical and technical insights of tumour mutational burden in non-small cell lung cancer

    Critical Reviews in Oncology/Hematology, Vol. 182

  5. Pancreatic steatosis and iron overload increases cardiovascular risk in non-alcoholic fatty liver disease

    Frontiers in Endocrinology, Vol. 14

2022

  1. Analysis of Exosomal Cargo Provides Accurate Clinical, Histologic and Mutational Information in Non-Small Cell Lung Cancer

    Cancers, Vol. 14, Núm. 13

  2. Clinical and pathological features of Merkel cell carcinoma: A 4-year follow-up observational retrospective study in Spain

    Cancer Epidemiology, Vol. 76

  3. Effect of clinical and histologic features on time to malignancy in 224 cases of oral leukoplakia treated by surgery

    Clinical Oral Investigations, Vol. 26, Núm. 8, pp. 5181-5188

  4. Matched Paired Primary and Recurrent Meningiomas Points to Cell-Death Program Contributions to Genomic and Epigenomic Instability along Tumor Progression

    Cancers, Vol. 14, Núm. 16

  5. Programmed Death-Ligand 1 (PD-L1) as Immunotherapy Biomarker in Breast Cancer

    Cancers, Vol. 14, Núm. 2

2021

  1. 3D printing novel in vitro cancer cell culture model systems for lung cancer stem cell study

    Materials Science and Engineering C, Vol. 122

  2. Analysis of the gut microbiota: An emerging source of biomarkers for immune checkpoint blockade therapy in non-small cell lung cancer

    Cancers, Vol. 13, Núm. 11

  3. Cancer epigenetic biomarkers in liquid biopsy for high incidence malignancies

    Cancers, Vol. 13, Núm. 12

  4. Characterization of circulating t cell receptor repertoire provides information about clinical outcome after pd-1 blockade in advanced non-small cell lung cancer patients

    Cancers, Vol. 13, Núm. 12

  5. Decellularized tracheal prelamination implant: A proposed bilateral double organ technique

    Artificial Organs, Vol. 45, Núm. 12, pp. 1491-1500

  6. Differentially methylated genes in proliferative verrucous leukoplakia reveal potential malignant biomarkers for oral squamous cell carcinoma

    Oral Oncology, Vol. 116